Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-16-651305
Filing Date
2016-07-19
Accepted
2016-07-19 17:26:19
Documents
71
Period of Report
2016-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d190912d10k.htm 10-K 682177
2 EX-23.1 d190912dex231.htm EX-23.1 1566
3 EX-24 d190912dex24.htm EX-24 8306
4 EX-31.1 d190912dex311.htm EX-31.1 5925
5 EX-31.2 d190912dex312.htm EX-31.2 5981
6 EX-32 d190912dex32.htm EX-32 3598
  Complete submission text file 0001193125-16-651305.txt   5299896

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cydy-20160531.xml EX-101.INS 769007
8 XBRL TAXONOMY EXTENSION SCHEMA cydy-20160531.xsd EX-101.SCH 71544
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cydy-20160531_cal.xml EX-101.CAL 62053
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cydy-20160531_def.xml EX-101.DEF 436127
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cydy-20160531_lab.xml EX-101.LAB 560759
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cydy-20160531_pre.xml EX-101.PRE 501540
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-K | Act: 34 | File No.: 000-49908 | Film No.: 161774151
SIC: 2834 Pharmaceutical Preparations